Immune mediated neuropathies in pregnancy and postpartum period

Document Type : Review Article

Authors

1 Associate Professor, Department of Neurological Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Assistant Professor, Department of Neurological Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Resident, Department of Neurological Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Introduction: Gillian- Barre- Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) are immune-mediated disorders of peripheral nervous system which presented with progressive symmetrical muscle weakness, deep tendon reflexes and sensory symptoms. This review study was performed with aim to investigate the effects of pregnancy and postpartum period on immune mediated neuropathies and also the effects of these neuropathies on the prognosis of pregnancy and treatment of these diseases during this period.
GBS evolves acutely in 2 to 4 weeks and in two third of cases, there is a history of viral or bacterial infections before the onset of symptoms. CIDP is a chronic auto-immune disorder that progresses at least for 8 weeks in comparison to GBS that evolves in 4 weeks.
In this article, we reviewed the effects of pregnancy and postpartum period on these diseases as well as the effects of GBS and CIDP on pregnancy and postpartum period in different articles performed in recent years and collected the appropriate treatments of these disorders during the pregnancy and postpartum period. This article could be a proper guideline for neurologists and obstetrics and gynecologists to treat and predict the prognosis of mothers with immune-mediated neuropathies.
 Conclusion:
Many immune mediated neuromuscular disorders occur in women at childbearing ages. Incidences of these disorders may affect the pregnancy and childbirth. Also, pregnancy may have influences in the symptoms and treatment of the mentioned disorders. GBS and CIDP are among the most important immune-mediated peripheral nervous system disorders. Recognizing the effects of GBS and CIDP during pregnancy and postpartum period and the effects of pregnancy on the process of these two disorders is so important.

Keywords

References

  1. Chan LY, Tsui MH, Leung TN. Guillain-Barré syndrome in pregnancy. Acta obstetricia et gynecologica Scandinavica 2004; 83(4):319-25.
  2. Parry GJ, Heiman-Patterson TD. Pregnancy and autoimmune neuromuscular disease. InSeminars in neurology 1988 (Vol. 8, No. 3, pp. 197-204).
  3. Kul PT, Logigian E. Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Pregnancy. Neurological Diseases and Pregnancy: A Coordinated Care Model for Best Management 2018: 248.
  4. Cheng Q, Jiang GX, Fredrikson S, Link H, de Pedro-Cuesta J. Increased incidence of Guillain-Barré syndrome postpartum. Epidemiology 1998: 601-4.
  5. Hughes RA, Hadden RD, Rees JH, Swan AV. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients. Brain: a journal of neurology 1998; 121(4):767-9.
  6. Barzegar M, Dastgiri S, Karegarmaher MH, Varshochiani A. Epidemiology of childhood Guillan-Barre syndrome in the north west of Iran. BMC Neurol 2007; 7:22.
  7. Vasudev R, Raina TR. A rare case of Guillain-Barré syndrome in pregnancy treated with plasma exchange. Asian journal of transfusion science 2014; 8(1):59.
  8. Raphaël JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain‐Barré syndrome. Cochrane Database of Systematic Reviews 2012(7).
  9. Sharma SR, Sharma N, Masaraf H, Singh SA. Guillain-Barré syndrome complicating pregnancy and correlation with maternal and fetal outcome in North Eastern India: A retrospective study. Annals of Indian Academy of Neurology 2015; 18(2):215.
  10. Kohle F, Kuwabara S, Lehmann HC. Chronic inflammatory demyelinating polyneuropathy and pregnancy: systematic review. J Neurol Neurosurg Psychiatry. 2021;92(5):473–8.
  11. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Annals of neurology 1999; 46(6):910-3.
  12. Kachru C, Bahadur A, Dagar M, Agrawal R. Diagnosing Gullian Barre Syndrome in the Post-partum Period: A Case Report. Journal of Medical Sciences and Health 2015; 1(1):21-23.
  13. Bolik A, Wissel J, Rolfs A. Guillain-Barré syndrome in pregnancy—two case reports and a discussion on management. Archives of gynecology and obstetrics 1995; 256(4):199-203.
  14. Watson WJ, Katz VL, Bowes Jr WA. Plasmapheresis during pregnancy. Obstetrics and gynecology 1990; 76(3 Pt 1):451-7.
  15. Brooks H, Christian AS, May AE. Pregnancy, anaesthesia and Guillain Barre syndrome. Anaesthesia 2000; 55(9):894-8.
  16. Nelson LH, McLEAN Jr WT. Management of Landry-Guillain-Barré syndrome in pregnancy. Obstetrics and gynecology 1985; 65(3 Suppl):25S-9S.
  17. Gu YW, Lin J, Zhang LX, Liang XM, Fan HG, Zhao L, et al. Classification of pregnancy complicating Guillain-Barré syndrome. Zhonghua yi xue za zhi 2019; 99(18):1401-5.
  18. Manley C, Geary F. An Incidence of Chronic Inflammatory Demyelinating Polyneuropathy in Pregnancy [28L]. Obstetrics & Gynecology 2017; 129(5):S128-9.
  19. Jacoby DR, Olding LB, Oldstone MB. Immunologic regulation of fetal-maternal balance. Advances in immunology 1984; 35:157-208.
  20. McCombe PA, McManis PG, Frith JA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy associated with pregnancy. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 1987; 21(1):102-4.
  21. Sax TW, Rosenbaum RB. Neuromuscular disorders in pregnancy. Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine 2006; 34(5):559-71.
  22. Danesi R, Del Tacca M. Teratogenesis and immunosuppressive treatment. InTransplantation proceedings 2004 (Vol. 36, No. 3, pp. 705-707) Elsevier.
  23. Nwosu EC, Tandon S, Breeze C, Enevoldson TP, Khaleeli AA. Chronic demyelinating polyneuropathy in pregnancy treated with intravenous immunoglobulin. BJOG: An International Journal of Obstetrics & Gynaecology 1999; 106(2):174-6.
  24. Hara K, Minami K, Takamoto K, Shiraishi M, Sata T. The prolonged effect of a muscle relaxant in a patient with chronic inflammatory demyelinating polyradiculoneuropathy. Anesthesia & Analgesia 2000; 90(1):224-6.
  25. Richter T, Langer KA, Koch T. Spinal anesthesia for cesarean section in a patient with chronic inflammatory demyelinating polyradiculoneuropathy. Journal of anesthesia 2012; 26(2):280-2.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Volume 24, Issue 2
April 2021
Pages 80-85

Files

Share

How to cite

Statistics